FERIPENAM 500MG Injection (Ferric Carboxymaltose 50Mg/Ml)

Composition:

Ferric Carboxymaltose 50 mg/mL

Description:

FERIPENAM 500 mg Vial contains Ferric Carboxymaltose, an intravenous iron preparation used to treat iron deficiency anemia when oral iron therapy is ineffective or not tolerated. It works by replenishing iron stores in the body, supporting red blood cell production, and improving hemoglobin levels.

Precautions:

FERIPENAM should be administered under medical supervision. Caution is advised in patients with known hypersensitivity to intravenous iron products, anemia not caused by iron deficiency, or active infections. It is not recommended during pregnancy or breastfeeding unless prescribed by a doctor. Patients should inform their physician about all other medications to avoid potential interactions.

Adverse Effects:

Possible side effects include nausea, headache, dizziness, flushing, or injection site reactions. Rarely, severe allergic reactions such as anaphylaxis may occur. Monitoring during and after infusion is recommended.

Storage:

Store below 25°C, protected from light and moisture. Keep out of reach of children and do not use after the expiry date.